NCT05148481View on ClinicalTrials.gov

A Study to Evaluate Safety and Pharmacokinetics of BIIB104 in Healthy Japanese and Non-Japanese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 23, 2021

Primary Completion Date

January 30, 2022

Study Completion Date

February 12, 2022

Conditions
Healthy Volunteer
Interventions
DRUG

BIIB104

Administered as specified in the treatment arm

DRUG

Placebo

Administered as specified in the treatment arm

Trial Locations (1)

92801

Research Site, Anaheim

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT05148481 - A Study to Evaluate Safety and Pharmacokinetics of BIIB104 in Healthy Japanese and Non-Japanese Participants | Biotech Hunter | Biotech Hunter